Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

[Patient suddenly breathless].

Lasseur M, Boucly A, Sitbon O.

Rev Prat. 2018 Sep;68(7):753-760. French. No abstract available.

PMID:
30869327
2.

Aztreonam plus clavulanate, tazobactam or avibactam for the treatment of metallo-β-lactamase-producing-Gram negative related infections.

Emeraud C, Escaut L, Boucly A, Fortineau N, Bonnin RA, Naas T, Dortet L.

Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00010-19. doi: 10.1128/AAC.00010-19. [Epub ahead of print]

PMID:
30858212
3.

Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension.

Weatherald J, Boucly A, Launay D, Cottin V, Prévot G, Bourlier D, Dauphin C, Chaouat A, Savale L, Jaïs X, Jevnikar M, Traclet J, De Groote P, Simonneau G, Hachulla E, Mouthon L, Montani D, Humbert M, Sitbon O.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800678. doi: 10.1183/13993003.00678-2018. Print 2018 Oct.

PMID:
30209196
4.

Risk stratification in pulmonary arterial hypertension.

Weatherald J, Boucly A, Sitbon O.

Curr Opin Pulm Med. 2018 Sep;24(5):407-415. doi: 10.1097/MCP.0000000000000510.

PMID:
30004992
5.

Clinical and Hemodynamic Correlates of Pulmonary Arterial Stiffness in Incident, Untreated Patients With Idiopathic Pulmonary Arterial Hypertension.

Chemla D, Weatherald J, Lau EMT, Savale L, Boucly A, Attal P, Jaïs X, Parent F, Girerd B, Simonneau G, Montani D, Humbert M, Sitbon O, Hervé P.

Chest. 2018 Oct;154(4):882-892. doi: 10.1016/j.chest.2018.06.015. Epub 2018 Jun 27.

PMID:
29940163
6.

Association Between BMI and Obesity With Survival in Pulmonary Arterial Hypertension.

Weatherald J, Huertas A, Boucly A, Guignabert C, Taniguchi Y, Adir Y, Jevnikar M, Savale L, Jaïs X, Peng M, Simonneau G, Montani D, Humbert M, Sitbon O.

Chest. 2018 Oct;154(4):872-881. doi: 10.1016/j.chest.2018.05.006. Epub 2018 May 22.

PMID:
29800550
7.

Age, risk and outcomes in idiopathic pulmonary arterial hypertension.

Hoeper MM, Boucly A, Sitbon O.

Eur Respir J. 2018 May 3;51(5). pii: 1800629. doi: 10.1183/13993003.00629-2018. Print 2018 May. No abstract available.

PMID:
29724788
8.

Soft X-ray Heterogeneous Radiolysis of Pyridine in the Presence of Hydrated Strontium-Hydroxyhectorite and its Monitoring by Near-Ambient Pressure Photoelectron Spectroscopy.

Boucly A, Rochet F, Arnoux Q, Gallet JJ, Bournel F, Tissot H, Marry V, Dubois E, Michot L.

Sci Rep. 2018 Apr 18;8(1):6164. doi: 10.1038/s41598-018-24329-8.

9.

Risk assessment in pulmonary arterial hypertension.

Boucly A, Weatherald J, Humbert M, Sitbon O.

Eur Respir J. 2018 Mar 29;51(3). pii: 1800279. doi: 10.1183/13993003.00279-2018. Print 2018 Mar. No abstract available.

PMID:
29599118
10.

CO oxidation activity of Pt, Zn and ZnPt nanocatalysts: a comparative study by in situ near-ambient pressure X-ray photoelectron spectroscopy.

Naitabdi A, Boucly A, Rochet F, Fagiewicz R, Olivieri G, Bournel F, Benbalagh R, Sirotti F, Gallet JJ.

Nanoscale. 2018 Apr 5;10(14):6566-6580. doi: 10.1039/c7nr07981h.

PMID:
29577122
11.

[Pulmonary veno-occlusive disease].

Boucly A, Girerd B, Bourlier D, Nemlaghi S, Caliez J, Savale L, Jaïs X, Dorfmüller P, Simonneau G, Sitbon O, Humbert M, Montani D.

Rev Mal Respir. 2018 Feb;35(2):160-170. doi: 10.1016/j.rmr.2017.11.005. Epub 2018 Mar 1. Review. French.

PMID:
29501213
12.

The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?

Weatherald J, Boucly A, Sahay S, Humbert M, Sitbon O.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):860-868. doi: 10.1164/rccm.201709-1840PP. No abstract available.

PMID:
29256625
13.

Acute decompensated pulmonary hypertension.

Savale L, Weatherald J, Jaïs X, Vuillard C, Boucly A, Jevnikar M, Montani D, Mercier O, Simonneau G, Fadel E, Sitbon O, Humbert M.

Eur Respir Rev. 2017 Nov 15;26(146). pii: 170092. doi: 10.1183/16000617.0092-2017. Print 2017 Dec 31. Review.

14.

Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.

Weatherald J, Boucly A, Chemla D, Savale L, Peng M, Jevnikar M, Jaïs X, Taniguchi Y, O'Connell C, Parent F, Sattler C, Hervé P, Simonneau G, Montani D, Humbert M, Adir Y, Sitbon O.

Circulation. 2018 Feb 13;137(7):693-704. doi: 10.1161/CIRCULATIONAHA.117.029254. Epub 2017 Oct 25.

PMID:
29070502
15.

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.

Boucly A, Cottin V, Nunes H, Jaïs X, Tazi A, Prévôt G, Reynaud-Gaubert M, Dromer C, Viacroze C, Horeau-Langlard D, Pison C, Bergot E, Traclet J, Weatherald J, Simonneau G, Valeyre D, Montani D, Humbert M, Sitbon O, Savale L.

Eur Respir J. 2017 Oct 19;50(4). pii: 1700465. doi: 10.1183/13993003.00465-2017. Print 2017 Oct.

PMID:
29051269
16.

Are indexed values better for defining exercise pulmonary hypertension?

Weatherald J, Boucly A, Lau E, Godinas L, Savale L, Jaïs X, Montani D, Sitbon O, Simonneau G, Humbert M, Chemla D, Hervé P.

Eur Respir J. 2017 Sep 9;50(3). pii: 1700240. doi: 10.1183/13993003.00240-2017. Print 2017 Sep. No abstract available.

17.

Energy-Level Alignment of a Hole-Transport Organic Layer and ITO: Toward Applications for Organic Electronic Devices.

Arnoux Q, Boucly A, Barth V, Benbalagh R, Cossaro A, Floreano L, Silly M, Sirotti F, Derat E, Carniato S, Bournel F, Gallet JJ, Fichou D, Tortech L, Rochet F.

ACS Appl Mater Interfaces. 2017 Sep 13;9(36):30992-31004. doi: 10.1021/acsami.7b06691. Epub 2017 Aug 31.

PMID:
28805058
18.

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, Chaouat A, Chabanne C, Bourdin A, Parent F, Montani D, Simonneau G, Humbert M, Sitbon O.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700889. doi: 10.1183/13993003.00889-2017. Print 2017 Aug.

19.

Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension.

O'Connell C, Amar D, Boucly A, Savale L, Jaïs X, Chaumais MC, Montani D, Humbert M, Simonneau G, Sitbon O.

Drug Saf. 2016 Apr;39(4):287-94. doi: 10.1007/s40264-015-0365-x. Review.

PMID:
26748508
20.

[Tunnelled central venous line-associated infections in patients with pulmonary arterial hypertension treated with intravenous prostacyclin].

Boucly A, O'Connell C, Savale L, O'Callaghan DS, Jaïs X, Montani D, Humbert M, Simonneau G, Sitbon O.

Presse Med. 2016 Jan;45(1):20-8. doi: 10.1016/j.lpm.2015.10.001. Epub 2015 Nov 4. French.

PMID:
26547673
21.

Clinical pharmacology of endothelin receptor antagonists used in the treatment of pulmonary arterial hypertension.

Chaumais MC, Guignabert C, Savale L, Jaïs X, Boucly A, Montani D, Simonneau G, Humbert M, Sitbon O.

Am J Cardiovasc Drugs. 2015 Feb;15(1):13-26. doi: 10.1007/s40256-014-0095-y. Review.

PMID:
25421754

Supplemental Content

Loading ...
Support Center